Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 27;222(Suppl 9):S794-S801.
doi: 10.1093/infdis/jiaa420.

Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can't Do?

Matthew R Kappus  1   2 , Cameron R Wolfe  1   2 , Andrew J Muir  1   2
Affiliations

Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can't Do?

Matthew R Kappus et al. J Infect Dis. .

Abstract

The opioid epidemic has resulted in an increase in organ donors with hepatitis C virus (HCV) infection in the United States. With the development of direct-acting antiviral regimens that offer high sustained virologic response rates even in the setting of immunosuppression after transplantation, these HCV-viremic organs are now being offered to transplant candidates with or without preexisting HCV infection. Strategies for HCV treatment with HCV-viremic organs have included delayed and preemptive approaches. This review will discuss key studies in the different solid organ transplants, recent reports of adverse events, and ethical and regulatory considerations. The efficacy of current HCV therapies has created this important opportunity to improve survival for patients with end-organ failure through greater access to organ transplantation and decreased waitlist mortality rate.

Keywords: antiviral agents; donor selection; hepatitis C; organ transplantation.

PubMed Disclaimer

Substances